Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
European Journal of Cancer (Oxford, England : 1990)
|
November 2, 2018
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort
M Kandel, C Allayous, S Dalle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 4, 2024
A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance 2 years later
A Di Meglio, J Havas, M Pagliuca, et al.
Genomics Data
|
October 21, 2015
Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patients
B Haibe-Kains, C Desmedt, A Di Leo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 17, 2025
Next-Generation Multicenter Studies: Using Artificial Intelligence to Automatically Process Unstructured Health Records of Patients with Lung Cancer across Multiple Institutions
M Aldea, L Zullo, V Levrat, et al.
Seminars in Cancer Biology
|
July 11, 2018
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning
F Klauschen, K-R Müller, A Binder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
S Gourgou-Bourgade, D Cameron, P Poortmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†
S Gourgou-Bourgade, D Cameron, P Poortmans, et al.
Nature Communications
|
September 21, 2017
Predictors of responses to immune checkpoint blockade in advanced melanoma
N Jacquelot, M P Roberti, D P Enot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2026
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival
Y Wang, D Drubay, S F Jonas, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
European Journal of Cancer (Oxford, England : 1990)
|
November 2, 2018
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort
M Kandel, C Allayous, S Dalle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 4, 2024
A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance 2 years later
A Di Meglio, J Havas, M Pagliuca, et al.
Genomics Data
|
October 21, 2015
Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patients
B Haibe-Kains, C Desmedt, A Di Leo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 17, 2025
Next-Generation Multicenter Studies: Using Artificial Intelligence to Automatically Process Unstructured Health Records of Patients with Lung Cancer across Multiple Institutions
M Aldea, L Zullo, V Levrat, et al.
Seminars in Cancer Biology
|
July 11, 2018
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning
F Klauschen, K-R Müller, A Binder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
S Gourgou-Bourgade, D Cameron, P Poortmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†
S Gourgou-Bourgade, D Cameron, P Poortmans, et al.
Nature Communications
|
September 21, 2017
Predictors of responses to immune checkpoint blockade in advanced melanoma
N Jacquelot, M P Roberti, D P Enot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2026
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival
Y Wang, D Drubay, S F Jonas, et al.
Page
of 6